Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.
Press releases published on October 1, 2025

LightIC Brings Silicon Photonics FMCW LiDAR to Market—with Instant Velocity Awareness
SAN JOSE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- LightIC, a pioneer in silicon photonics–based FMCW LiDAR, today announced the general availability of its automotive FMCW LiDAR, LARK. By combining Frequency-Modulated Continuous Wave (FMCW) technology …

National Cybersecurity Alliance Launches 22nd Annual Cybersecurity Awareness Month
WASHINGTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The National Cybersecurity Alliance (NCA), the nation’s leading nonprofit dedicated to promoting a more secure and interconnected world, has announced the launch of the 22nd annual Cybersecurity Awareness Month …

NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
CALABASAS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today …

Vocodia Holdings Corp Bolsters Leadership Recruiting Activist Investor Paul Taylor as Chairman and Interim COO, Announces Aggressive Strategic Pivot
BOCA RATON, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp (OTC: VHAI), a pioneer in AI-driven customer engagement solutions, today announced the unanimous election of Paul Taylor as Chairman of the Board and interim Chief Operating Officer, …

Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference
Los Angeles, CA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced …

Telos Launches Xacta.ai, Dramatically Cutting Cyber Compliance Timelines with AI-Driven Automation
ASHBURN, Va., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leader in cyber risk management and compliance solutions, today announced the launch of Xacta.ai™ the AI capability at the core of the Xacta® cyber governance, risk and …

New Dayforce Podcast Makes Sense of Work – One Piece at a Time
MINNEAPOLIS and TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the launch of Piece of Work, a new narrative-driven podcast diving …

Thrive Appoints Kirti Gavri as SVP, Head of Corporate Development
BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Thrive, a global technology outsourcing provider for managed AI, cybersecurity, cloud, and IT managed services, today named Kirti Gavri as SVP, head of corporate development, to fuel the company’s continued growth …

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base
Pr. Yann Gouëffic and affiliates (FRANCE-PAD) cover ~8% of all CLTI cases in France BERKELEY, Calif, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next- …

Genetec continue d’accroître sa part du marché mondial des logiciels de contrôle d’accès, selon le dernier rapport Omdia
MONTRÉAL, 01 oct. 2025 (GLOBE NEWSWIRE) -- Selon le rapport 2025 sur le Contrôle d’accès récemment publié par le cabinet d’études international Omdia, Genetec Inc. (“Genetec”), le leader mondial des logiciels de sécurité physique d’entreprise, continue d’ …

CISO Global Strengthens Balance Sheet, Positions for Growth and Strategic Opportunities
Scottsdale, AZ, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ: CISO) a leading provider of AI-powered cybersecurity software and compliance services, today announced it is well-positioned to accelerate sales growth and pursue strategic …

Global Rare Earth Elements Market Size Projected to Reach $8.14 Billion By 2032 with a Significant Increase in Demand Expected
PALM BEACH, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The rising demand for consumer durables such as tablets, laptops, and smartphones is one of the factors driving the consumption of rare earth elements. The demand for …

Genetec continues to expand its share of the global access control software market, according to latest Omdia report
MONTRÉAL, Oct. 01, 2025 (GLOBE NEWSWIRE) -- According to the newly released 2025 Access Control Report from global research firm Omdia, Genetec Inc. (“Genetec”), the global leader in enterprise physical security software, continues to expand its share of …

Vemanti Group Signs Agreement to Take 100% Ownership of ONUS Pro
Irvine, CA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTC: VMNT) today announced that it has signed a definitive agreement to acquire the remaining 49% equity interest in XPLOR Technology Pte. Ltd. (“XPLOR”), the …

Myseum, Inc. Partners with Creative Agency Spitball for Branding and Advertising of the New “Picture Party by Myseum” Social Sharing Platform
“Picture Party by Myseum,” launching this fall, is an all-new advanced function of the Myseum platform that will make it easier and even more fun to share photos and videos with friends, family and gatherings of all kinds. NEW BRUNSWICK, N.J., Oct. 01, …

Inuvo Appoints Rob Buchner as Chief Operating Officer to Accelerate Growth of IntentKey
LITTLE ROCK, Ark., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced the appointment of Rob Buchner as Chief Operating Officer, a newly created role designed …

Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease
Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) levels and increased brain myelin volume, resulting in promising functional improvements in children with Canavan Disease NEW YORK, Oct. …

MorningAI Unveils Autonomous Growth Platform for Brands
SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- MorningAI today announced the first autonomous growth platform that puts enterprise-level marketing capabilities into the hands of every business. Brands simply enter their company website and can have work …

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
Dotinurad is a next-generation URAT1 inhibitor in two Phase 3 clinical trials with potential for best-in-class safety and efficacy Urica sold dotinurad to Crystalys Therapeutics in 2024 in exchange for equity and a 3% royalty on future net sales of …